Correlation Between Serum Chloride and Anion Gap in DKA PatientsNCT05598866
Correlation Between Serum Chloride and Anion Gap Levels in DKA Patients
An observational study of Correlation Between Serum Chloride and Anion Gap in DKA Patients, run by Mervat Mokhles Fathi Sayed at 1 site in Egypt.
Trial summary
2.2 Aim(s) of the Research (50 words max): 1. To examine the description and correlation of changes in the serum chloride levels and changes in the anion gap values before and after fluid resuscitation in patients with DKA and to examine the description and correlation of changes in the serum chloride. 2. Read more about this study
- Who is it for?
- Ages 15 to 70 years
- Conditions the study is for
- Correlation Between Serum Chloride and Anion Gap in DKA Patients
- How many people
- 54 participants
- Where
- 1 siteEgypt
- Study dates
- Oct 2022to Oct 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 70 years
- All sexes
- Child, Adult, Older adult
Study population: any patients admitted to intensive care unit, critical care unit in Assuit university from……to…….. * Blood glucose level >250 mg/dl ( normal 70-100) * Ph<7.3 ( normal PH 7.35- 7.45) * Hco3<15 m mol/litre ( normal HCO3 22-26) * Serum chloride before resucitation <107m mol/litre (normal 96- 106) * Urea <6.5 m mol/litre * S.create <120 m mol/litre
Who may be able to join
- any patients admitted to intensive care unit, critical care unit in Assuit university from 15 yrs to 70
- Blood glucose level >250 mg/dl ( normal 70-100)
- Ph<7.3 ( normal PH 7.35- 7.45)Hco3<15 m mol/litre ( normal HCO3 22-26)
- Serum chloride before resucitation <107m mol/litre (normal 96- 106)
- Urea <6.5 m mol/litre
- S.create <120 m mol/litre
Who cannot join
- Patients receiving chemotherapy, diuretics, corticosteroids, laxatives
- Patients diagnosed to have Addison disease
- Patients with chronic kidney disease and acute kidney injury, end stage renal disease, renal tubular acidosis
- Patients with malabsorpion syndrome ( celiac disease, crohn's , celiac disease )
- Patients with chronic respiratory acidosis (asthma, COPD, pulmonary fibrosis, neuromuscular disorders)
- Patients with diarrhea
Trial locations and contacts
1 site in 1 country.
Mokhles Fathy Sayed contact
About this study
Official title: Correlation Between the Serum Chloride Levels and the Anion Gap Values in the Initial Fluid Resuscitation in DKA Patients and Its Relation to Outcome
2.2 Aim(s) of the Research (50 words max):
- To examine the description and correlation of changes in the serum chloride levels and changes in the anion gap values before and after fluid resuscitation in patients with DKA and to examine the description and correlation of changes in the serum chloride.
- relation of serum chloride and outcome in patients with DKA
Read the detailed description
Diabetic ketoacidosis (DKA) is one of the most serious and acute complications of diabetes. DKA is a significant contributor to mortality, costs, and poor quality of life.
The total incidence of DKA tends to increase, mainly due to an increase in type 2 diabetes cases and obesity.
DKA consists of the biochemical triad of hyperglycemia, ketonemia, and metabolic acidosis resulting from absolute or relative insulin deficiency and an increase in counter-regulatory hormones. These life-threatening consequences produce severe body water deficit, the accumulation of ketone bodies, and electrolyte disturbances.
Hyperglycemia develops because of three processes: increased gluconeogenesis, accelerated glycogenolysis, and impaired glucose utilization by peripheral tissues. The hyperglycemia will lead to glycosuria and osmotic diuresis, resulting in hyperosmolar intracellular dehydration.
In DKA, fluid deficits may be up to 10% of total body weight and electrolyte deficits in the body, one of which is chloride.
In DKA, lipolysis resulting in high circulating levels of free fatty acids may occur. These free fatty acids are taken up by the liver and oxidized to ketone bodies. Excessive production of ketone bodies in the anionic form can cause high plasma anion gap. Ketone bodies are relatively strong acids that dissociate at physiologic pH. The dissociation in the form of H+ ions will be buffered by bicarbonate. When the plasma bicarbonate concentrations decrease, a high anion gap acidosis metabolic (HAGMA) develops. The anion gap calculation formula is [Na+ (Cl-+ HCO3)]. Based on diagnostic criteria, the anion gap value in DKA >10. The increased anion gap is a predictor of metabolic acidosis, and the degree of metabolic acidosis can be estimated by the size of the anion gap. Initial management of adult patients with DKA is rehydration with normal saline fluid (0.9% NaCl) intravenously and insulin administration (when the serum potassium levels <3.3 mEq/L). The initial dose of normal saline infusion is 15-20 mL/kg/hour over the first hour.
Subsequent amount of fluid given depends on the hydration status, hemodynamic conditions, and electrolyte levels. Electrolyte levels are monitored after 2 hours of initial fluid resuscitation.
The goals of rapid rehydration are to improve the circulatory volume and tissue perfusion, clear ketone bodies, and correct electrolyte imbalances. Normal saline contains 154 mEq/L chloride and 154 mEq/L sodium.
The chloride concentration of saline is higher than that of human plasma (97-107 mEq/L).
Normal saline (0.9% sodium chloride) is a low-cost and easy-to-find crystalloid fluid which becomes fluid choice by doctors in some cases. However, normal saline is now under observation due to concerns about hyperchloremic metabolic acidosis, oliguria, prolonged acidosis, and coagulopathy. Consistent data are found regarding increased serum chloride levels associated with complications of acidosis, AKI, or electrolyte disturbances after being given at least 2 liters of normal saline. An increase in the chloride levels is not counterbalanced by an increase in the bicarbonate ion concentrations in plasma. Although the anion gap values decrease, acidosis still occurs. Thus, normal anion gap metabolic acidosis (NAGMA) or hyperchloremic acidosis arises.
Blood glucose level <200 mg/dL, serum bicarbonate level >15 mEq/L, pH >7.3, and normal anion gap are recovery signs of DKA.12 causes of hyperchloremia include: Gastrointestinal problems, such as vomiting or diarrhea. heat exposure, Diabetes insipidus, Some medications, particularly hormones as estrogens, diuretics, corticosteroids,and certain,chemotherapy Starvation due to eating disorders, severe malnourishment, or problems absorbing nutrients from food.
Addison's disease, diabetes insipidus,burns, kidney disease, kidney failure, and renal tubular acidosis
Hypochloremia can be caused by:
Diarrhea Vomiting Excessive sweating Kidney problems Chronic respiratory acidosis, Syndrome of inappropriate antidiuretic hormone excretion (SIADH), Metabolic alkalosis, Use of certain medications like corticosteroids, diuretics, laxatives, and bicarbonates
What is being measured
The primary outcome is the main question the study is designed to answer.
1-Change in serum chloride levels before and after fluid resucitation in DKA patients. 2- change in anion gap level before and after fluid resuscitation in DKA patients.
- change in serum chloride level before and after fluid resuscitation in DKA patients.
- change in anion gap level before and after fluid resuscitation in DKA patients.
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Oct 2022
- Study startOct 2022 (estimated)
- Primary completionOct 2023 (estimated)
- Study completionOct 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Correlation Between Serum Chloride and Anion Gap in DKA PatientsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 54 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mervat Mokhles Fathi Sayed
- Sponsor type
- University, hospital or other
- Collaborators
- Assiut University
- Responsible party
- Sponsor-investigator, Mervat Mokhles Fathi Sayed, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05598866
- Sponsor's protocol ID
- Serum chloride in DKA
- Status last verified
- Oct 2022
- First submitted
- 19 Aug 2022
- Last updated
- 28 Oct 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 28 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Correlation Between the Serum Chloride Levels and the Anion Gap Values in the Initial Fluid Resuscitation in DKA Patients and Its Relation to Outcome
- ClinicalTrials.gov ID
- NCT05598866
- Acronym / sponsor ID
- Serum chloride in DKA
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 54 participants (estimated)
- Lead sponsor
- Mervat Mokhles Fathi SayedUniversity, hospital or other
- Collaborators
- Assiut University
- Study start
- Oct 2022 (estimated)
- Primary completion
- Oct 2023 (estimated)
- Study completion
- Oct 2024 (estimated)
- First posted
- 28 Oct 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
2.2 Aim(s) of the Research (50 words max):
- To examine the description and correlation of changes in the serum chloride levels and changes in the anion gap values before and after fluid resuscitation in patients with DKA and to examine the description and correlation of changes in the serum chloride.
- relation of serum chloride and outcome in patients with DKA
Detailed description
Diabetic ketoacidosis (DKA) is one of the most serious and acute complications of diabetes. DKA is a significant contributor to mortality, costs, and poor quality of life.
The total incidence of DKA tends to increase, mainly due to an increase in type 2 diabetes cases and obesity.
DKA consists of the biochemical triad of hyperglycemia, ketonemia, and metabolic acidosis resulting from absolute or relative insulin deficiency and an increase in counter-regulatory hormones. These life-threatening consequences produce severe body water deficit, the accumulation of ketone bodies, and electrolyte disturbances.
Hyperglycemia develops because of three processes: increased gluconeogenesis, accelerated glycogenolysis, and impaired glucose utilization by peripheral tissues. The hyperglycemia will lead to glycosuria and osmotic diuresis, resulting in hyperosmolar intracellular dehydration.
In DKA, fluid deficits may be up to 10% of total body weight and electrolyte deficits in the body, one of which is chloride.
In DKA, lipolysis resulting in high circulating levels of free fatty acids may occur. These free fatty acids are taken up by the liver and oxidized to ketone bodies. Excessive production of ketone bodies in the anionic form can cause high plasma anion gap. Ketone bodies are relatively strong acids that dissociate at physiologic pH. The dissociation in the form of H+ ions will be buffered by bicarbonate. When the plasma bicarbonate concentrations decrease, a high anion gap acidosis metabolic (HAGMA) develops. The anion gap calculation formula is [Na+ (Cl-+ HCO3)]. Based on diagnostic criteria, the anion gap value in DKA >10. The increased anion gap is a predictor of metabolic acidosis, and the degree of metabolic acidosis can be estimated by the size of the anion gap. Initial management of adult patients with DKA is rehydration with normal saline fluid (0.9% NaCl) intravenously and insulin administration (when the serum potassium levels <3.3 mEq/L). The initial dose of normal saline infusion is 15-20 mL/kg/hour over the first hour.
Subsequent amount of fluid given depends on the hydration status, hemodynamic conditions, and electrolyte levels. Electrolyte levels are monitored after 2 hours of initial fluid resuscitation.
The goals of rapid rehydration are to improve the circulatory volume and tissue perfusion, clear ketone bodies, and correct electrolyte imbalances. Normal saline contains 154 mEq/L chloride and 154 mEq/L sodium.
The chloride concentration of saline is higher than that of human plasma (97-107 mEq/L).
Normal saline (0.9% sodium chloride) is a low-cost and easy-to-find crystalloid fluid which becomes fluid choice by doctors in some cases. However, normal saline is now under observation due to concerns about hyperchloremic metabolic acidosis, oliguria, prolonged acidosis, and coagulopathy. Consistent data are found regarding increased serum chloride levels associated with complications of acidosis, AKI, or electrolyte disturbances after being given at least 2 liters of normal saline. An increase in the chloride levels is not counterbalanced by an increase in the bicarbonate ion concentrations in plasma. Although the anion gap values decrease, acidosis still occurs. Thus, normal anion gap metabolic acidosis (NAGMA) or hyperchloremic acidosis arises.
Blood glucose level <200 mg/dL, serum bicarbonate level >15 mEq/L, pH >7.3, and normal anion gap are recovery signs of DKA.12 causes of hyperchloremia include: Gastrointestinal problems, such as vomiting or diarrhea. heat exposure, Diabetes insipidus, Some medications, particularly hormones as estrogens, diuretics, corticosteroids,and certain,chemotherapy Starvation due to eating disorders, severe malnourishment, or problems absorbing nutrients from food.
Addison's disease, diabetes insipidus,burns, kidney disease, kidney failure, and renal tubular acidosis
Hypochloremia can be caused by:
Diarrhea Vomiting Excessive sweating Kidney problems Chronic respiratory acidosis, Syndrome of inappropriate antidiuretic hormone excretion (SIADH), Metabolic alkalosis, Use of certain medications like corticosteroids, diuretics, laxatives, and bicarbonates
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 15 to 70 years
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- any patients admitted to intensive care unit, critical care unit in Assuit university from……to…….. * Blood glucose level >250 mg/dl ( normal 70-100) * Ph<7.3 ( normal PH 7.35- 7.45) * Hco3<15 m mol/litre ( normal HCO3 22-26) * Serum chloride before resucitation <107m mol/litre (normal 96- 106) * Urea <6.5 m mol/litre * S.create <120 m mol/litre
Key inclusion criteria (6 listed)
- any patients admitted to intensive care unit, critical care unit in Assuit university from 15 yrs to 70
- Blood glucose level >250 mg/dl ( normal 70-100)
- Ph<7.3 ( normal PH 7.35- 7.45)Hco3<15 m mol/litre ( normal HCO3 22-26)
- Serum chloride before resucitation <107m mol/litre (normal 96- 106)
- Urea <6.5 m mol/litre
Key exclusion criteria (6 listed)
- Patients receiving chemotherapy, diuretics, corticosteroids, laxatives
- Patients diagnosed to have Addison disease
- Patients with chronic kidney disease and acute kidney injury, end stage renal disease, renal tubular acidosis
- Patients with malabsorpion syndrome ( celiac disease, crohn's , celiac disease )
- Patients with chronic respiratory acidosis (asthma, COPD, pulmonary fibrosis, neuromuscular disorders)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
1-Change in serum chloride levels before and after fluid resucitation in DKA patients. 2- change in anion gap level before and after fluid resuscitation in DKA patients.
Time frame: 2 years
1. change in serum chloride level before and after fluid resuscitation in DKA patients. 2. change in anion gap level before and after fluid resuscitation in DKA patients.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Oct 2022.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mokhles Fathy Sayed contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Correlation Between Serum Chloride and Anion Gap in DKA Patients, run by Mervat Mokhles Fathi Sayed at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 28 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Mervat Mokhles Fathy (01002488659, Mokhlesmervat@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
1-Change in serum chloride levels before and after fluid resucitation in DKA patients. 2- change in anion gap level before and after fluid resuscitation in DKA patients. (time frame: 2 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2022.